StockTipsArenaBeta

BUY Divi's Laboratories Limited — Akshay Bhagwat, JM Financial

BUYDivi's Laboratories Limited

byAkshay Bhagwat, JM FinancialHorizon: Intraday21 Jul 2026, 1:47 pm ISTvia ET Now

Entry₹7,225Stated
Target₹7,500
Total upside +3.81% (call closed)
Stop loss₹7,115-1.52% risk
Exit—No position was opened
ExpiredNA
Follow Akshay Bhagwat for new callsGet alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 18 active Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Jul 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

5 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·21 Jul · today

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·14 Jul · 6d ago

(opens in new tab)
Neutral / worth noting (2)

Divis Laboratories reduces carbon footprint in FY 2025-26

NewsGoogle News·15 Jul · 5d ago

(opens in new tab)

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·15 Jul · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.